Journal of the American Chemical Society · 2012 · 65 citations · 34 references
MedicineMedicinal ChemistryPharmacologyDrug DesignMolecular PharmacologyStructure-activity RelationshipsAnalgesic PharmacologyAnti-inflammatory PharmacologyDrug-metabolizing EnzymesEnzyme InhibitionInflammation PharmacologyOpioid AnalgesicsCyclooxygenase InhibitorsDirected MutagenesisEndocannabinoid SignalingEnzyme ActivityEnzyme Activity AssaysNonsteroidal Anti-inflammatory Drug PharmacologyNsaid TherapyX-ray Structure Determination
In addition to inhibiting the cyclooxygenase (COX)-mediated biosynthesis of prostanoids, various widely used nonsteroidal anti-inflammatory drugs (NSAIDs) enhance endocannabinoid signaling by blocking the anandamide-degrading membrane enzyme fatty acid amide hydrolase (FAAH). The X-ray structure of FAAH in complex with the NSAID carprofen, along with site-directed mutagenesis, enzyme activity assays, and NMR analysis, has revealed the molecular details of this interaction, providing information that may guide the design of dual FAAH-COX inhibitors with superior analgesic efficacy.
34
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Benjamin F. Cravatt, Dan K. Giang, Stephen P. Mayfield et al. · Nature · 1996 · 2.1K citations
Benjamin F. Cravatt, Kristin Demarest, Matthew P. Patricelli et al. · Proceedings of the National Academy of Sciences · 2001 · 1.3K citations · Full text
Medicine, Neuroscience, Pharmacology +13
Elizabeth A. Meade, William L. Smith, David L. DeWitt · Journal of Biological Chemistry · 1993 · 1.3K citations · Full text
Medicine, Biochemistry, Pharmacology +15
Control of pain initiation by endogenous cannabinoids
Antonio Calignano, Giovanna La Rana, Andrea Giuffrida et al. · Nature · 1998 · 1.1K citations
Medicine, Neurobiology, Pharmacology +14